Compare · Skin Substitutes & Allografts
Products with published specifications
| Activate Matrix | AmnioDefend FT Matrix | Orion | AmchoPlast | |
|---|---|---|---|---|
| Manufacturer | IWC | IWC | Legacy | Cellution |
| Tissue type | Human placental-derived allograft: amniotic and chorionic membranes and intermediate (spongy) layer | Human placental-derived allograft: amniotic and chorionic membranes and intermediate (spongy) layer | Human amniotic membrane allograft derived from placental birth tissue (prescreened mother, planned delivery) | Human amnion - intermediate layer - chorion membrane allograft (dHAICM) |
| Regulatory status | Described in the brochure as 361 HCT/P | Described in the brochure as 361 HCT/P | Per the IFU and brochure, the FDA Tissue Reference Group confirmed in writing that Orion meets the criteria for regulation solely under Section 361 of the PHS Act (21 CFR Part 1271) | The brochure does not print an HCT/P 361 designation. TBD |
| HCPCS code | Q4301, Activate Matrix, per square centimeter (as printed in the brochure) | Q4379, Amnio Defend Matrix, per square centimeter (as printed in the brochure) | Q4276 (as printed in the brochure) | Q4316 (as printed in the brochure) |
To order, contact info@fortify-medical.com.